Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer extends support for study in prophylactic treatment of hemophilia A

July 15, 2004

Rotigotine reduces RLS symptoms in phase IIb trial

July 15, 2004

Combination treatment with olive oil extract effective against HIV

July 15, 2004

Amarin to acquire Laxdale

July 15, 2004

Genistein induces apoptosis in HIV-infected cells in vitro

July 15, 2004

CCR5 antagonist with potent anti-HIV activity in vitro

July 15, 2004

Anti-CCR5 monoclonal antibody PRO-140 controls HIV-1 replication in vivo

July 15, 2004

Spheramine granted fast track status for advanced Parkinson's disease

July 15, 2004

Potent glycogen synthase kinase-3beta inhibitors effective in vivo

July 15, 2004

Nuvelo closes phase II alfimeprase study early

July 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...